At a glance
- Originator Nonindustrial source
- Class Antivirals; Coumarins
- Mechanism of Action HIV integrase inhibitors; HIV protease inhibitors; RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 31 Jul 1998 No-Development-Reported for HIV-1 infections in USA (Unknown route)
- 19 Dec 1996 New profile
- 19 Dec 1996 Preclinical development for HIV-1 infections in USA (Unknown route)